Slow electons can be used to destroy cancer cells - but how exactly this happens has not been well understood. Now scientists have been able to demonstrate that a previously little-observed effect actually plays a pivotal role: Due to a process called interatomic Coulombic decay, an ion can pass on additional energy to surrounding atoms. This frees a huge nu […]
An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.
Researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
Researchers have discovered that the tumor suppressor MEG3 adopts a complex three-dimensional structure to fulfill its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture. The results of this study might help to advance diagnosis and treatment of certain types of cancer.
A new international study has identified a new drug target for treating glioblastoma. This target is part of a never-before defined cellular pathway found to contribute to the spread and proliferation of a dangerous subset of cancer cells, called glioma stem cells.
Antibodies are key players in our immune system and have been used as biopharmaceuticals. The collaborative groups including researchers have found previously unknown contact sites in the antibody molecule that are involved in its binding to a cognate receptor, challenging the traditional paradigm of the molecular mechanism of antibody function.